
Stephen Gottschalk
Chair, Department of Bone Marrow Transplantation & Cellular Therapy · St Jude Children's Research Hospital
Credentials: · · · ·
History
PresentDepartment of Bone Marrow Transplantation & Cellular Therapy · St Jude Children's Research Hospital
PresentCenter of Excellence for Pediatric Immuno-Oncology · St Jude Children's Research Hospital

- 1998–2001
Hematology and Medical Oncology
- 1995–1998
Internal Medicine
Research
Journal of Clinical Oncology · 2015 · Last of 26 authors · Corresponding · 855 citations
JAMA Oncology · 2017 · 747 citations
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
Journal of Clinical Investigation · 2016 · 595 citations

59 papers

53 papers

34 papers · 1 as a resident

30 papers

28 papers
- MO
28 papers

27 papers · 2 as a fellow

26 papers
Grants
- 2022–2027
T32 Training Program in Pediatric Immuno-Oncology and Immunotherapy
National Cancer Institute · T32
Contact PI · $993.5K · St. Jude Children's Research Hospital
- 2022–2027
Enhancing B7-H3-CAR T Cell Therapy for Pediatric Solid Tumors
National Cancer Institute · R01
PI · $2.9M · St. Jude Children's Research Hospital
- 2018–2024
Genetic Approaches to Optimize CAR T Cells for Glioblastoma Therapy
National Institute of Neurological Disorders and Stroke · R01
PI · $2.7M · Northwestern University
- 1997–2024
Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders
National Heart, Lung, and Blood Institute · P01
Project lead · $2.9M · St. Jude Children's Research Hospital
Clinical trials
- 2024–2028
Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
Principal investigator · Recruiting · Phase 1
St. Jude Children's Research Hospital
- 2016–2034
Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
Principal investigator · Suspended · Phase 1, Phase 2
St. Jude Children's Research Hospital
- 2007–2010
Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)
Principal investigator · Withdrawn · Phase 1
Baylor College of Medicine
- 2007–2013
LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)
Principal investigator · Completed · Phase 1
Baylor College of Medicine



